Ventilator Pressure and Optimization of Compliance and Hemodynamics
VPOCH
1 other identifier
interventional
24
1 country
1
Brief Summary
In preterm infants \< 34 weeks' gestation at birth receiving respiratory support with invasive positive pressure ventilation, the positive end-expiratory pressure (PEEP) of best compliance will increase the cardiac output and improve oxygenation. This study may emphasize using point-of-care echocardiography along with electrical impedance tomography (EIT) to optimize ventilator settings in preterm infants. Infants will be randomized to a 4-hour crossover period of increasing and decreasing PEEP in random order from baseline to determine compliance, oxygenation, and cardiac hemodynamics at each step using echocardiography (ECHO) and EIT measurements. There will be a 15-minute washout period after changes prior to data collection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2024
CompletedFirst Posted
Study publicly available on registry
July 22, 2024
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedAugust 8, 2025
August 1, 2025
9 months
July 5, 2024
August 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in cardiac index with increase/decrease in PEEP as measured by ECHO and EIT
During a 4 hour cross-over period on either intervention
PEEP of best compliance and best oxygenation as per EIT measurements
During a 4 hour cross-over period on either intervention
Secondary Outcomes (7)
Tidal volume variation
During a 4 hour cross-over period on either intervention
Oxygen saturation index
During a 4 hour cross-over period on either intervention
End-expiratory lung impedance (EELI), End-inspiratory lung impedance (EILI)
During a 4 hour cross-over period on either intervention
Transcutaneous carbon dioxide (TcCO2) values in response to varying PEEP levels
During a 4 hour cross-over period on either intervention
Respiratory Severity Score (RSS)
During a 4 hour cross-over period on either intervention
- +2 more secondary outcomes
Study Arms (2)
cardiac hemodynamics and respiratory status assessment with increasing PEEP
EXPERIMENTALInfants will be randomized to the order of changes in PEEP levels during mechanical ventilation - increase followed by decrease in PEEP. Baseline parameters looking into cardiac hemodynamics as well as compliance and respiratory mechanics will be assessed using EIT
cardiac hemodynamics and respiratory status assessment with decreasing PEEP
ACTIVE COMPARATORInfants will be randomized to the order of changes in PEEP levels during mechanical ventilation - decrease followed by increase in PEEP. Baseline parameters looking into cardiac hemodynamics as well as compliance and respiratory mechanics will be assessed using EIT
Interventions
Changes in the ventilator PEEP and its effect on lung and cardiac hemodynamics
Changes in the ventilator PEEP and its effect on lung and cardiac hemodynamics
Eligibility Criteria
You may qualify if:
- Preterm infants with recovering respiratory distress syndrome (RDS) who were born at a gestational age \< 34 weeks and are receiving respiratory support via conventional mechanical ventilation or on HFJV.
- Post-natal age \> 7 days and less than 1 month (outside golden week protocol)
- Gestational age ≥ 21 weeks and ≤ 34 week
- Infants with written informed consent obtained from legal guardian
You may not qualify if:
- Blood culture-positive sepsis
- Congenital anomalies affecting respiration
- Cyanotic or ductal-dependent congenital heart disease
- Newborns who are considered too unstable for study enrolment per neonatology attending
- Newborns on pressors or steroids for maintaining cardiac output
- Non-invasive ventilation or newborn with significant BPD (bronchopulmonary dysplasia) with pulmonary hypertension (HTN)
- Open skin wounds or abrasions on the chest wall.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Univerisity of Alabama
Birmingham, Alabama, 35233, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kulsajan S Bhatia, MD
University of Alabama at Birmingham
- PRINCIPAL INVESTIGATOR
Colm P Travers, MD
University of Alabama at Birmingham
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neonatal Perinatal Fellow
Study Record Dates
First Submitted
July 5, 2024
First Posted
July 22, 2024
Study Start
August 1, 2025
Primary Completion
May 1, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
August 8, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share